Terms ending in 2037
Every in-force patent on Hemanext Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,583,192 | Anaerobic Blood Storage and Pathogen Inactivation Method In force · Low confidence | Hemanext Inc. | In force | Low confidence | |
| US 11,147,876 | Anaerobic Blood Storage and Pathogen Inactivation Method In force · High confidence | Hemanext Inc. | In force | High confidence | |
| US 11,911,471 | Anaerobic Blood Storage and Pathogen Inactivation Method In force · High confidence | Hemanext Inc. | In force | High confidence | |
| US 12,364,760 | Anaerobic Blood Storage and Pathogen Inactivation Method In force · Medium confidence | Hemanext Inc. | In force | Medium confidence | |
| US 11,090,331 | Methods and Treatment for Reducing the Risk of an Inflammatory Response In force · Medium confidence | Hemanext Inc. | In force | Medium confidence | |
| US D961,765 | Blood Storage Bag In force · High confidence | Hemanext Inc. | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.